Nikhil Narang, MD
@Nikhil15
HF/Transplant/LVAD Cardiologist, Advocate Christ Medical Center @advocatehealth β’ @UCCardsfellows @MedChiefs alum β’ Dad β’ #JACCHF #SoMe Team @JACCJournals
09-10-2008 05:06:05
3,2K Tweets
2,7K Followers
1,5K Following
Outstanding new commentary on trial design/differences b/t DAPA-MI & EMPACT-MI on use of SGLT2i post MI in JACC Journals #JACC by Muthu Vaduganathan + Alex Peikert
Can expected early improvements in EF post MI counter the risk of long term worsening HF?
π: jacc.org/doi/10.1016/j.β¦
